AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Pertuzumab'
:
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Publication Year: 2011
DOI: https://doi.org/10.1056/nejmoa1113216
Abstract:
Add to Library
Authors:
José Baselga
Javier Cortés
Sung‐Bae Kim
Seock‐Ah Im
Roberto Hegg
Young‐Hyuck Im
Laslo Roman
José Luiz Pedrini
Jurandyr Moreira de Andrade
Adam Knott
Emma Clark
Mark Benyunes
Graham Ross
Sandra M. Swain
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Publication Year: 2012
DOI: https://doi.org/10.1056/nejmoa1113216
Abstract:
Add to Library
Authors:
José Baselga
Javier Cortés
Sung‐Bae Kim
Seock‐Ah Im
Roberto Hegg
Young‐Hyuck Im
Laslo Roman
José Luiz Pedrini
Jurandyr Moreira de Andrade
Adam Knott
Emma Clark
Mark Benyunes
Graham Ross
Sandra M. Swain
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Publication Year: 2015
DOI: https://doi.org/10.1056/nejmoa1413513
Abstract:
Add to Library
Authors:
Sandra M. Swain
José Baselga
Sung‐Bae Kim
Jungsil Ro
Angelo Di Leo
Mario Campone
Eva Ciruelos
Jean-Marc Ferrero
Andreas Schneeweiß
Sarah Heeson
Emma Clark
Graham Ross
Mark Benyunes
Javier Cortés
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Publication Year: 2011
DOI: https://doi.org/10.1016/s1470-2045(11)70336-9
Abstract:
Add to Library
Authors:
Luca Gianni
Tadeusz Pieńkowski
Young‐Hyuck Im
Laslo Roman
Ling‐Ming Tseng
Mei-Ching Liu
Aña Lluch
Elżbieta Starosławska
Juan de la Haba-Rodríguez
Seock‐Ah Im
José Luiz Pedrini
Brigitte Poirier
Paolo Morandi
Semiglazov Vf
Vichien Srimuninnimit
Giulia Bianchi
Tania Szado
Jayantha Ratnayake
Graham Ross
Pinuccia Valagussa
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
Publication Year: 2004
DOI: https://doi.org/10.1016/s1535-6108(04)00083-2
Abstract:
Add to Library
Authors:
Matthew C. Franklin
Kendall D. Carey
F.F. Vajdos
Daniel J. Leahy
Abraham M. de Vos
Mark X. Sliwkowski
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Publication Year: 2017
DOI: https://doi.org/10.1056/nejmoa1703643
Abstract:
Add to Library
Authors:
Gϋnter von Minckwitz
Marion Procter
Evandro de Azambuja
Angelo Di Leo
Mark Benyunes
Giuseppe Viale
Thomas Suter
Amal Arahmani
Nathalie Rouchet
Emma Clark
Adam Knott
István Láng
Christelle Lévy
Denise A. Yardley
José Bines
Richard D. Gelber
Martine Piccart
José Baselga
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Publication Year: 2012
DOI: https://doi.org/10.1016/s1470-2045(11)70336-9
Abstract:
Add to Library
Authors:
Luca Gianni
Tadeusz Pieńkowski
Young‐Hyuck Im
Laslo Roman
Ling‐Ming Tseng
Mei-Ching Liu
Aña Lluch
Elżbieta Starosławska
Juan de la Haba-Rodríguez
Seock‐Ah Im
José Luiz Pedrini
Brigitte Poirier
Paolo Morandi
Semiglazov Vf
Vichien Srimuninnimit
Giulia Bianchi
Tania Szado
Jayantha Ratnayake
Graham Ross
Pinuccia Valagussa
The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells
Publication Year: 2004
DOI: https://doi.org/10.1158/0008-5472.can-03-3856
Abstract:
Add to Library
Authors:
Rita Nahta
Mien‐Chie Hung
Francisco J. Esteva
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
Publication Year: 2013
DOI: https://doi.org/10.1016/s1470-2045(13)70130-x
Abstract:
Add to Library
Authors:
Sandra M. Swain
Sung‐Bae Kim
Javier Cortés
Jungsil Ro
Semiglazov Vf
Mario Campone
Eva Ciruelos
Jean-Marc Ferrero
Andreas Schneeweiß
Adam Knott
Emma Clark
Graham Ross
Mark Benyunes
José Baselga
Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
Publication Year: 2009
DOI: https://doi.org/10.1158/0008-5472.can-08-4597
Abstract:
Add to Library
Authors:
Werner Scheuer
Thomas Friess
Helmut Burtscher
Birgit Bossenmaier
Josef Endl
Max Hasmann
Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy
Publication Year: 2010
DOI: https://doi.org/10.1200/jco.2009.24.2024
Abstract:
Add to Library
Authors:
José Baselga
Karen A. Gelmon
Shailendra Verma
Andrew Wardley
Pierfranco Conté
David Miles
Giulia Bianchi
Javier Cortés
Virginia McNally
Graham Ross
Pierre Fumoleau
Luca Gianni
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Publication Year: 2013
DOI: https://doi.org/10.1093/annonc/mdt182
Abstract:
Add to Library
Authors:
Andreas Schneeweiß
Stephen Chia
Tamas Hickish
Vernon Harvey
Alexandru Eniu
Roberto Hegg
Christoph Tausch
Jae Hong Seo
Yi-Fang Tsai
Jayantha Ratnayake
Virginia McNally
Graham Ross
Javier Cortés
Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer
Publication Year: 2005
DOI: https://doi.org/10.1200/jco.2005.03.184
Abstract:
Add to Library
Authors:
David B. Agus
Michael S. Gordon
Charles Taylor
Ronald B. Natale
Beth Y. Karlan
David S. Mendelson
Michael F. Press
David E. Allison
Mark X. Sliwkowski
G. Lieberman
Stephen M. Kelsey
Gwen Fyfe
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Publication Year: 2018
DOI: https://doi.org/10.1016/s1470-2045(17)30716-7
Abstract:
Add to Library
Authors:
Sara A. Hurvitz
Miguel Martín
W. Fraser Symmans
Kyung Hae Jung
Chiun‐Sheng Huang
Alastair M. Thompson
Nadia Harbeck
Vicente Valero
Daniil Stroyakovskiy
Hans Wildiers
Mario Campone
Jean Francois Boileau
Matthias W. Beckmann
Karen Afenjar
R Fresco
Hans‐Joachim Helms
Jin Xu
Yvonne G. Lin
Joseph A. Sparano
Dennis J. Slamon
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
Publication Year: 2016
DOI: https://doi.org/10.1016/s1470-2045(16)00163-7
Abstract:
Add to Library
Authors:
Luca Gianni
Tadeusz Pieńkowski
Young‐Hyuck Im
Ling‐Ming Tseng
Mei-Ching Liu
Aña Lluch
Elżbieta Starosławska
Juan de la Haba-Rodríguez
Seock‐Ah Im
José Luiz Pedrini
Brigitte Poirier
Paolo Morandi
Semiglazov Vf
Vichien Srimuninnimit
Giulia Bianchi
Domenico Magazzù
Virginia McNally
Hannah Douthwaite
Graham Ross
Pinuccia Valagussa
Found 16139 results in 0.608 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"